These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 493296)

  • 1. Abnormal pattern of amphetamine locomotion after 6-OHDA lesion of anteromedial caudate.
    Fink JS; Smith GP
    Pharmacol Biochem Behav; 1979 Jul; 11(1):23-30. PubMed ID: 493296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine.
    Taylor JR; Robbins TW
    Psychopharmacology (Berl); 1986; 90(3):390-7. PubMed ID: 3097729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesolimbic dopamine neurons: effects of 6-hydroxydopamine-induced destruction and receptor blockade on drug-induced rotation of rats.
    Kelly PH; Moore KE
    Psychopharmacology (Berl); 1977 Nov; 55(1):35-41. PubMed ID: 414259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.
    Clarke PB; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1988; 96(4):511-20. PubMed ID: 3149775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal modulation of nucleus accumbens: behavioral evidence from amphetamine-induced activity profiles.
    Whishaw IQ; Mittleman G
    Behav Neural Biol; 1991 May; 55(3):289-306. PubMed ID: 1905533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P; Robbins TW
    Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity.
    Joyce EM; Stinus L; Iversen SD
    Neuropharmacology; 1983 Sep; 22(9):1141-5. PubMed ID: 6415508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats.
    Whishaw IQ; Fiorino D; Mittleman G; Castañeda E
    Brain Res; 1992 Mar; 576(1):1-11. PubMed ID: 1381257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi.
    Kelly PH; Roberts DC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):137-43. PubMed ID: 6413984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesolimbic dopamine and early post-6-OHDA lesion enhanced responses to d-amphetamine.
    Lynch MR; Carey RJ
    Pharmacol Biochem Behav; 1989 Feb; 32(2):577-80. PubMed ID: 2498910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH; Swerdlow NR; Koob GF
    Behav Neurosci; 1988 Aug; 102(4):544-52. PubMed ID: 3139012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ; Pycock CJ
    Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to D-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens.
    Simon H; Taghzouti K; Gozlan H; Studler JM; Louilot A; Herve D; Glowinski J; Tassin JP; Le Moal M
    Brain Res; 1988 May; 447(2):335-40. PubMed ID: 3134111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity.
    Jones GH; Robbins TW
    Pharmacol Biochem Behav; 1992 Nov; 43(3):887-95. PubMed ID: 1448483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.
    Kelly PH; Seviour PW; Iversen SD
    Brain Res; 1975 Sep; 94(3):507-22. PubMed ID: 1171714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different behavioral responses to L-DOPA after anterolateral or posterolateral hypothalamic injections of 6-hydroxydopamine.
    Ervin GN; Fink JS; Young RC; Smith GP
    Brain Res; 1977 Sep; 132(3):507-20. PubMed ID: 303138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.